CVE-2022-26389
An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.29%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.
- CVSS 3.1
- 7.7 HIGHCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H
- EPSS
- 0.29% probability · 21th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-284
- Source
- productsecurity@baxter.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.